Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

NCT06071962 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

558

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Pain Syndrome
Pain, Chronic
Chronic Pain
Chronic Pain Syndrome
Back Pain
Lower Back Pain
Lower Back Pain Chronic

Interventions

DRUG: Adezunap (AP707)
DRUG: Placebo

Sponsor

Apurano Pharmaceuticals GmbH